A disorder that mainly targets the dopamine-producing neurons in the brain, causing tremors, rigidity, balance issues and cognitive changes.
RELATED ARTICLES
There Are No Failures in Parkinson’s Research; Only Setbacks
Parkinson’s disease can’t be slowed or cured, but researchers like Dr. Williamson are working to change that.
Parkinson’s disease does not mean living with limits
Thanks to Parkinson’s Disease research and treatment advances, astronaut Rich Clifford continues to live his life without limitations.
Researcher Profile: Ian Reynolds
Ian leads the Small Molecule Discovery Group at Teva Pharmaceuticals, where he is focused on drug discovery for neurological and neurogenerative diseases, such as Parkinson’s and multiple sclerosis (MS).
Cellular Pioneering: Dr. Jeffrey Conn
A pioneer in mental health research, Dr. Jeffrey Conn works to advance treatments for neurological and psychiatric disorders, such as schizophrenia and Parkinson's disease.
Researcher Profile: Pablo Sardi
Dr. Pablo Sardi is a Research and Development director in the Neurobiology Unit at Sanofi. He started his career in Boston doing post-doctoral research at Harvard and moved to Genzyme in 2007 to pursue his interest in investigating disease mechanism to develop therapies to treat neurodegenerative diseases.
Researcher Profile: Darryle Schoepp
Darryle Schoepp has been involved in drug research for over 30 years, and wears many hats at Merck.
